TY - JOUR
T1 - Interleukin-6 signaling drives fibrosis in unresolved inflammation
AU - Fielding, Ceri A.
AU - Jones, Gareth Wyn
AU - McLoughlin, Rachel Mary
AU - McLeod, Louise
AU - Hammond, Victoria J.
AU - Uceda, Javier
AU - Williams, Anwen Sian
AU - Lambie, Mark
AU - Foster, Thomas L.
AU - Liao, Chia-Te
AU - Rice, Christopher M.
AU - Greenhill, Claire J.
AU - Colmont, Chantal Sophie
AU - Hams, Emily
AU - Coles, Barbara
AU - Kift-Morgan, Ann
AU - Newton, Zarabeth
AU - Craig, Katherine J.
AU - Williams, John David
AU - Williams, Geraint Trefor
AU - Davies, Simon J.
AU - Humphreys, Ian R.
AU - O'Donnell, Valerie Bridget
AU - Taylor, Philip Russel
AU - Jenkins, Brendan J.
AU - Topley, Nicholas
AU - Jones, Simon Arnett
PY - 2014/1/16
Y1 - 2014/1/16
N2 - Fibrosis in response to tissue damage or persistent inflammation is a pathological hallmark of many chronic degenerative diseases. By using a model of acute peritoneal inflammation, we have examined how repeated inflammatory activation promotes fibrotic tissue injury. In this context, fibrosis was strictly dependent on interleukin-6 (IL-6). Repeat inflammation induced IL-6-mediated T helper 1 (Th1) cell effector commitment and the emergence of STAT1 (signal transducer and activator of transcription-1) activity within the peritoneal membrane. Fibrosis was not observed in mice lacking interferon-gamma (IFN-gamma), STAT1, or RAG-1. Here, IFN-gamma and STAT1 signaling disrupted the turnover of extracellular matrix by metalloproteases. Whereas IL-6-deficient mice resisted fibrosis, transfer of polarized Th1 cells or inhibition of MMP activity reversed this outcome. Thus, IL-6 causes compromised tissue repair by shifting acute inflammation into a more chronic profibrotic state through induction of Th1 cell responses as a consequence of recurrent inflammation.
AB - Fibrosis in response to tissue damage or persistent inflammation is a pathological hallmark of many chronic degenerative diseases. By using a model of acute peritoneal inflammation, we have examined how repeated inflammatory activation promotes fibrotic tissue injury. In this context, fibrosis was strictly dependent on interleukin-6 (IL-6). Repeat inflammation induced IL-6-mediated T helper 1 (Th1) cell effector commitment and the emergence of STAT1 (signal transducer and activator of transcription-1) activity within the peritoneal membrane. Fibrosis was not observed in mice lacking interferon-gamma (IFN-gamma), STAT1, or RAG-1. Here, IFN-gamma and STAT1 signaling disrupted the turnover of extracellular matrix by metalloproteases. Whereas IL-6-deficient mice resisted fibrosis, transfer of polarized Th1 cells or inhibition of MMP activity reversed this outcome. Thus, IL-6 causes compromised tissue repair by shifting acute inflammation into a more chronic profibrotic state through induction of Th1 cell responses as a consequence of recurrent inflammation.
UR - http://orca.cf.ac.uk/61183/
U2 - 10.1016/j.immuni.2013.10.022
DO - 10.1016/j.immuni.2013.10.022
M3 - Article (Academic Journal)
C2 - 24412616
VL - 40
SP - 40
EP - 50
JO - Immunity
JF - Immunity
SN - 1074-7613
IS - 1
ER -